Clinical Trial Update: Atorvastatin (Lipitor) Therapy in Patients With Clinically Isolated Syndrome (CIS) at Risk for Multiple Sclerosis [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating atorvastatin (Lipitor) in patients with clinically isolated syndrome at risk for multiple sclerosis has completed, with results poste…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Clinically Isolated Syndrome
• Multiple Sclerosis

Drugs mentioned

• Lipitor (atorvastatin)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Multiple Sclerosis | Phase 2 | Status: COMPLETED | Results posted: 2011-11-03